Roche returns diabetes drug rights to partner Ipsen (Bloomberg, 2 February 2011)

01 Feb 2011


Patient withdrawal from clinical trials has prompted Swiss pharmaceutical company Roche Holding AG to return rights to the experimental diabetes drug tapsoglutide to French firm Ipsen SA.

Full article


Share this story